TRIP.COM-S
09961
TME-SW
01698
BABA-W
09988
4
NTES-S
09999
5
TENCENT
00700
(FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 6.84%1.16T | 4.27%811.83B | 3.87%551.45B | 7.04%260.05B | 3.67%1.08T | 3.70%778.59B | 4.66%530.89B | 1.38%242.96B | 9.95%1.05T | 11.12%750.79B |
Operating income | 6.84%1.16T | 4.27%811.83B | 3.87%551.45B | 7.04%260.05B | 3.67%1.08T | 3.70%778.59B | 4.66%530.89B | 1.38%242.96B | 9.95%1.05T | 11.12%750.79B |
Cost of sales | -5.40%-974.95B | -2.82%-681.08B | -2.71%-465.74B | -6.45%-220.28B | -2.87%-924.96B | -2.65%-662.38B | -3.54%-453.44B | -0.35%-206.94B | -9.32%-899.16B | -10.54%-645.25B |
Operating expenses | -5.40%-974.95B | -2.82%-681.08B | -2.71%-465.74B | -6.45%-220.28B | -2.87%-924.96B | -2.65%-662.38B | -3.54%-453.44B | -0.35%-206.94B | -9.32%-899.16B | -10.54%-645.25B |
Gross profit | 15.13%183.87B | 12.52%130.75B | 10.66%85.71B | 10.42%39.77B | 8.59%159.7B | 10.11%116.2B | 11.70%77.45B | 7.69%36.02B | 13.95%147.07B | 14.78%105.54B |
Selling expenses | -19.49%-47.95B | -15.16%-31.12B | -10.77%-21.12B | -15.60%-9.25B | -6.25%-40.13B | -4.79%-27.02B | -4.87%-19.07B | 8.04%-8.01B | 2.51%-37.77B | -1.60%-25.79B |
Administrative expenses | 8.47%-8.89B | 12.27%-6.43B | 15.46%-4.11B | 20.99%-1.98B | 12.15%-9.71B | 1.01%-7.33B | -1.48%-4.86B | -1.58%-2.5B | 4.40%-11.05B | 5.33%-7.41B |
Research and development expenses | -3.89%-17.03B | -4.94%-12.65B | 0.08%-8.25B | 3.63%-4.03B | 2.96%-16.39B | 3.79%-12.05B | 1.82%-8.26B | 4.52%-4.19B | -3.43%-16.89B | -2.45%-12.53B |
Profit from asset sales | -33.11%1.53B | ---- | ---- | ---- | 65.55%2.28B | 20.50%1.48B | --1.48B | --472M | 79.79%1.38B | 64.09%1.23B |
Impairment and provision | 54.32%-2.36B | ---- | ---- | ---- | ---5.17B | ---- | ---- | ---- | ---- | ---- |
-Goodwill impairment | 74.58%-799M | ---- | ---- | ---- | ---3.14B | ---- | ---- | ---- | ---- | ---- |
-Other impairment is provision | 22.86%-1.56B | ---- | ---- | ---- | ---2.03B | ---- | ---- | ---- | ---- | ---- |
Special items of operating profit | -9.09%-70.43B | -6.41%-50.31B | -6.17%-34.03B | -9.34%-16.81B | -2.46%-64.56B | -2.44%-47.28B | -0.81%-32.05B | 0.74%-15.37B | -6.70%-63.01B | -8.00%-46.15B |
Operating profit | 48.84%38.74B | 26.02%30.25B | 23.84%18.2B | 19.81%7.7B | 31.95%26.03B | 61.13%24B | 138.36%14.7B | 166.79%6.43B | 376.29%19.72B | 228.59%14.9B |
Financing cost | -0.52%-2.9B | -0.82%-1.97B | -3.62%-1.29B | -1.86%-601M | -36.80%-2.88B | -38.78%-1.95B | -50.24%-1.24B | -71.01%-590M | -73.62%-2.11B | -83.81%-1.41B |
Special items of earning before tax | 84.55%15.7B | 84.96%11.65B | 90.00%7.77B | -0.25%1.97B | 326.83%8.51B | 283.29%6.3B | 236.44%4.09B | 139.59%1.97B | 31.92%-3.75B | -183.03%-3.44B |
Earning before tax | 62.84%51.54B | 40.86%39.92B | 40.70%24.68B | 16.10%9.07B | 128.24%31.65B | 182.00%28.34B | 649.34%17.54B | 367.86%7.81B | 637.48%13.87B | 293.69%10.05B |
Tax | 18.05%-6.88B | 12.44%-6.13B | 15.79%-3.72B | -5.66%-1.7B | -100.98%-8.39B | -95.45%-7B | -141.40%-4.42B | -166.83%-1.61B | -121.30%-4.18B | -110.40%-3.58B |
After-tax profit from continuing operations | 92.03%44.66B | 58.33%33.8B | 59.72%20.96B | 18.81%7.37B | 139.99%23.26B | 229.91%21.35B | 2,472.94%13.12B | 276.21%6.2B | 316.95%9.69B | 660.28%6.47B |
Earning after tax | 92.03%44.66B | 58.33%33.8B | 59.72%20.96B | 18.81%7.37B | 139.99%23.26B | 229.91%21.35B | 2,472.94%13.12B | 276.21%6.2B | 316.95%9.69B | 660.28%6.47B |
Minority profit | 462.75%3.3B | 304.06%2.29B | 323.21%1.19B | 479.03%235M | -32.08%-910M | 164.58%567M | 132.00%280M | 88.24%-62M | 24.04%-689M | -16.45%-878M |
Profit attributable to shareholders | 71.14%41.36B | 51.63%31.51B | 53.98%19.77B | 13.88%7.13B | 132.82%24.17B | 182.77%20.78B | 827.22%12.84B | 309.33%6.26B | 391.57%10.38B | 357.82%7.35B |
Basic earnings per share | 79.84%13.83 | 57.94%10.44 | 57.46%6.44 | 14.57%2.28 | 131.63%7.69 | 181.28%6.61 | 808.89%4.09 | 307.29%1.99 | 388.70%3.32 | 351.92%2.35 |
Diluted earnings per share | 76.48%13.43 | 55.81%10.19 | 56.93%6.34 | 15.82%2.27 | 137.07%7.61 | 194.59%6.54 | 839.53%4.04 | 304.17%1.96 | 379.13%3.21 | 344.00%2.22 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS |
Audit Opinions | Unaudited opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | Deloitte Guan Huang Chen Fang, PricewaterhouseCoopers | -- | -- | -- | Deloitte Guan Huang Chen Fang, PricewaterhouseCoopers | -- | -- | -- | Deloitte Guan Huang Chen Fang, PricewaterhouseCoopers | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.